Blindness following bilateral neck dissection. A case report and review of the literature.

Blindness Neck dissection Oral cancer Oropharyngeal cancer

Journal

International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872

Informations de publication

Date de publication:
2020
Historique:
received: 15 10 2020
revised: 28 10 2020
accepted: 29 10 2020
pubmed: 10 11 2020
medline: 10 11 2020
entrez: 9 11 2020
Statut: ppublish

Résumé

Visual loss is a very rare but dramatic complication of such an indispensable standard procedure in head and neck tumor surgery such as the cervical lymphadenectomy (neck dissection). We present a review of the literature and a new case of a postoperative blindness of a 65-year-old man with type 2 diabetes who underwent a unilateral radical neck dissection, a contralateral modified radical neck dissection and a hemimandibulectomy for an oropharyngeal squamous cell carcinoma. By now there have been only 15 clinical cases of total blindness published during the last 60 years. In 13 cases blindness followed a bilateral radical neck dissection whereas in 2 cases blindness occurred after a combined selective and modified radical neck dissection. Ischemia of the optic nerve due to intraoperative hypotension, blood loss and venous congestion were the major etiological aspects of blindness. Perioperative management of differentiated volume and blood administration, blood pressure management and a close postoperative ophthalmological check seem to be of a major importance for prevention and early detection of visual deterioration. Nevertheless, there are no clear predicative factors for blindness after neck dissection and the prognosis is unfavorable. Even though postoperative vision loss is a rare and devastating complication, this current case and the review of the literature show that it occurs every once in a while following standard operations to the head and neck. Patients undergoing high-risk procedures should have to be informed that there is a slight risk of perioperative vision loss and this should be highlighted in the standard declaration of consent.

Identifiants

pubmed: 33166820
pii: S2210-2612(20)31025-7
doi: 10.1016/j.ijscr.2020.10.138
pmc: PMC7652710
pii:
doi:

Types de publication

Case Reports

Langues

eng

Pagination

201-205

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Br J Oral Maxillofac Surg. 2004 Dec;42(6):494-500
pubmed: 15544877
Arch Otolaryngol Head Neck Surg. 1991 Nov;117(11):1304-6
pubmed: 1747239
Head Neck. 1997 Mar;19(2):148-52
pubmed: 9059874
Eur Arch Otorhinolaryngol. 1997;254(9-10):478-80
pubmed: 9438123
Ann Fr Anesth Reanim. 1995;14(1):37-40
pubmed: 7677284
Auris Nasus Larynx. 2008 Jun;35(2):308-12
pubmed: 17981414
Arch Otolaryngol Head Neck Surg. 2000 Feb;126(2):220-3
pubmed: 10680875
Head Neck. 1990 Jul-Aug;12(4):342-5
pubmed: 2193905
Am J Ophthalmol. 2008 Apr;145(4):604-610
pubmed: 18358851
Rev Stomatol Chir Maxillofac. 1994;95(3):226-32
pubmed: 8029632
Graefes Arch Clin Exp Ophthalmol. 1992;230(4):301-8
pubmed: 1505758
Neuroophthalmology. 2001 Sep;26(2):85-92
pubmed: 12510694
Anesth Analg. 2001 Dec;93(6):1417-21, table of contents
pubmed: 11726416
Anesth Analg. 2005 Jan;100(1):192-5
pubmed: 15616077
Head Neck. 1993 Jul-Aug;15(4):308-12
pubmed: 8360052
J Laryngol Otol. 2012 Apr;126(4):418-20
pubmed: 22004842
Clin Ophthalmol. 2010 Mar 04;4:95-100
pubmed: 20234774
J Craniomaxillofac Surg. 2016 Oct;44(10):1737-1742
pubmed: 27580851
Int J Surg. 2018 Dec;60:132-136
pubmed: 30342279
J Laryngol Otol. 1990 Feb;104(2):154-6
pubmed: 2324625
Am J Otolaryngol. 2002 Jan-Feb;23(1):56-9
pubmed: 11791251
Arch Surg. 1964 Feb;88:271-4
pubmed: 14082818
Klin Oczna. 2010;112(1-3):63-6
pubmed: 20572508
J Laryngol Otol. 2001 Feb;115(2):158-60
pubmed: 11320839
Am J Otolaryngol. 1999 Sep-Oct;20(5):340-5
pubmed: 10512147
J Laryngol Otol. 1960 Nov;74:880-5
pubmed: 13770965
Mayo Clin Proc. 1973 Oct;48(10):713-7
pubmed: 4745543
J Craniomaxillofac Surg. 2019 Dec;47(12):1963-1967
pubmed: 31810845
Oral Oncol. 2003 Feb;39(2):130-7
pubmed: 12509965

Auteurs

Alexandra Krasnikova (A)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Oral and Maxillofacial Surgery at Campus Benjamin Franklin, Berlin, Germany.

Kilian Kreutzer (K)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Oral and Maxillofacial Surgery at Campus Benjamin Franklin, Berlin, Germany.

Stefan Angermair (S)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine at Campus Benjamin Franklin, Berlin, Germany.

Max Heiland (M)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Oral and Maxillofacial Surgery at Campus Benjamin Franklin, Berlin, Germany.

Steffen Koerdt (S)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Oral and Maxillofacial Surgery at Campus Benjamin Franklin, Berlin, Germany. Electronic address: steffen.koerdt@charite.de.

Classifications MeSH